We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

1519:HKEXJ&T Global Express Limited Analysis

Data as of 2026-06-14 - not real-time

NT$791.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Fortune Electric is trading at TWD 791, well below its 20‑day SMA (≈834) and 50‑day SMA (≈854), with a neutral RSI around 42 and a bearish MACD histogram. Volatility is elevated at roughly 57% over the past 30 days and the beta of ~0.62 suggests modest market correlation, while the stock sits near a technical support level of TWD 744 and faces resistance near TWD 997. Valuation metrics are stretched: the trailing P/E of 56.5 far exceeds the industry average of ~30, and the price‑to‑book of 30.3 dwarfs typical ratios, while the DCF‑derived fair value of about TWD 139 implies a substantial premium.
Fundamentally, the company delivers impressive profitability—ROE of 58% and operating margin above 21%—and strong cash generation (operating cash flow > TWD 5 bn). The dividend yield of 1.14% is backed by a payout ratio near 64% and a solid cash balance, supporting sustainability. Growth prospects are bolstered by a 7.6% revenue increase and expansion into EV‑charging infrastructure, yet the current market price embeds a high growth premium that may need correction before upside potential can be realized.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Price below 20‑day and 50‑day SMAs
  • Bearish MACD signal
  • Approaching technical support at TWD 744

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong earnings growth and high ROE
  • Elevated valuation multiples relative to peers
  • Robust cash flow and manageable debt levels

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustainable dividend with healthy payout ratio
  • Strategic expansion into electric‑vehicle charging
  • Consistently high profitability and cash generation

Key Metrics & Analysis

Financial Health

Revenue Growth7.60%
Profit Margin18.57%
P/E Ratio56.5
ROE58.33%
ROA12.36%
Debt/Equity29.53
P/B Ratio30.3
Op. Cash FlowNT$5.1B
Free Cash FlowNT$2.2B
Industry P/E30.6

Technical Analysis

TrendNeutral
RSI42.5
SupportNT$744.00
ResistanceNT$997.00
MA 20NT$834.55
MA 50NT$854.44
MA 200NT$783.63
MACDBearish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Fair ValueNT$139.22
Target PriceNT$926.33
Upside/Downside17.11%
GradeOvervalued
TypeGrowth
Dividend Yield1.14%

Risk Assessment

Beta0.62
Volatility57.10%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.